What is INDV's dilution risk score?

INDV has a latest available DilutionScore record of 16/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for INDV, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for INDV?

DilutionWatch tracks 25 SEC filing types for INDV including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect INDV shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For INDV, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for INDV tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for INDV. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

INDV Dilution Risk Score: 16/100 (LOW)

Score Breakdown

📋 Offering Ability

17

💰 Cash Runway

0

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

35

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

🔁 Convertible Conversion model 15%

• Convertible debt present: 10.2% potential dilution

🔔 Track INDV — Get forecast alerts →

Market Data

Market Cap$4.26B

Shares Outstanding118.01M

Float110.12M

Cash$222.00M

Debt$487.00M

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	16/100	DilutionWatch score record
Shares Outstanding	118.01M	Verified float table or market cache
Public Float	110.12M	Verified float table or market cache
Market Cap	$4.26B	Market data cache
Cash Runway	98.7 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 3, 8-K 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 73.6% shares (2026Q1 vs prior)

11 institutional holders · 33.31M shares

#1 BARCLAYS PLC 19.18M shares

#2 MORGAN STANLEY 10.00M shares

#3 GOLDMAN SACHS GROUP INC 3.25M shares

+ 8 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.30M

Days to Cover5.7

% of Float10.3%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

8-K 8K EVENT 2026-03-17

4 INSIDER TRANSACTION 2026-03-17

8-K 8K EVENT 2026-03-13

4 INSIDER TRANSACTION 2026-03-13

4 INSIDER TRANSACTION 2026-03-11

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual INDV Dilution Snapshot

Indivior Pharmaceuticals, Inc. (INDV) has a DilutionScore of 16/100, rated Low dilution risk. Score date: September 12, 2026.

Recent SEC activity tracked for INDV: 8-K on 2026-03-17; 4 on 2026-03-17; 8-K on 2026-03-13.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.